Austin, TX, April 20, 2011 --(PR.com
)-- Bioo Scientific continues to expand its line of kits designed to increase the flexibility of next generation sequencing library preparation with the launch of the AIR™ DNA Fragmentation Kit. The AIR™ DNA Fragmentation Kit offers a cost-effective procedure for the fragmentation of genomic DNA in next generation sequencing sample prep and has been optimized to physically shear uniform fragments of genomic DNA. This fragmentation step is a critical first step for next generation sequencing of genomic DNA.
The AIR™ DNA Fragmentation Kit was developed in collaboration with Eureka Genomics, a San Francisco bay area next-generation sequencing service provider which specializes in Illumina GAIIx sequencing and advanced bioinformatics analysis of sequence data. This collaboration allowed them to merge Bioo Scientific expertise in the development of unique library preparation solutions for next generation sequencing along with Eureka Genomics’ extensive experience as a service provider to improve traditional genomic DNA fragmentation protocol in a novel way. The AIR DNA Fragmentation Kit fragments DNA more efficiently than traditional nebulization protocols offering 30% greater DNA recovery than traditional fragmentation protocols. This kit contains nebulizers, a proprietary fragmentation buffer and complete instructions. AIR DNA Fragmentation Kit is designed to prepare libraries for either the Illumina/Solexa or the Roche 454 sequencing platform.
The AIR™ DNA Fragmentation Kit contains a redesigned nebulizer and optimized buffers and protocol that result in highly reproducible DNA shearing, with DNA fragment length distribution ideal for next generation sequencing library preparation. "The AIR™ DNA Fragmentation Kit is highly optimized and reduces the costs of library preparation while yielding consistent results," said Dr. Heather Koshinsky, Chief Scientific Officer at Eureka Genomics.
About Bioo Scientific Corporation
Bioo Scientific Corporation is an Austin, TX based biotechnology company that provides innovative solutions to the life science industry. Bioo Scientific offers a complete portfolio of products, which offer increased sensitivity, flexibility and speed to next-generation sequencing.
Bioo Scientific’s products are used around the world and can be purchased both directly or through our global distribution network that markets our products in more than 40 countries. For more information about Bioo Scientific, visit www.biooscientific.com.
About Eureka Genomics
Eureka Genomics is a privately held company and leader in the advanced bioinformatics analysis of next-generation sequencing data, which it applies to the discovery of novel microorganisms associated with cancers and other life threatening diseases.
Eureka Genomics further leverages its proprietary algorithms and biological problem-solving expertise by providing collaborative, high quality sequencing and analysis services on a cost-effective basis to a broad range of university, governmental and industry researchers around the world. For more information about Eureka Genomics, visit www.eurekagenomics.com.